# Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

> **NCT00005840** · PHASE1 · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 35 (actual)

## Conditions studied

- Endometrial Clear Cell Adenocarcinoma
- Endometrial Serous Adenocarcinoma
- Stage III Uterine Corpus Cancer
- Stage IV Uterine Corpus Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Cisplatin
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT00005840
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-07
- **Primary completion:** 2009-07
- **Final completion:** —
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2014-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005840, "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00005840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*